<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04856423</url>
  </required_header>
  <id_info>
    <org_study_id>2020SDU-QILU-1026</org_study_id>
    <nct_id>NCT04856423</nct_id>
  </id_info>
  <brief_title>Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer</brief_title>
  <official_title>Ultra-sensitivity Quantitative Fecal Immunochemical Test Improve Diagnostic Accuracy in Detecting Colorectal Advanced Adenoma and Colorectal Cancer: a Multicenter, Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Binzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weihai Municipal Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Lixia District of Jinan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early detecting and removing of colorectal advanced adenomas can reduce the incidence of&#xD;
      colorectal cancer. Because of the less bleeding of advanced adenomas, sensitivities of the&#xD;
      common used quantitative fecal immunochemical tests (qFITs) are unsatisfying.&#xD;
      Ultra-sensitivity qFIT(us-qFIT) can determine extremely low fecal hemoglobin concentration&#xD;
      compared with the common used qFIT. This study will prove the diagnostic accuracy of us-qFIT&#xD;
      in detecting colorectal advanced adenomas.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early detection of CRC in a curable stage can reduce mortality but not morbidity. The&#xD;
      majority of colorectal cancer is thought to arise from precancerous lesions through the&#xD;
      adenoma-carcinoma pathway. Detecting and removing of colorectal advanced adenomas can reduce&#xD;
      incidence of colorectal cancer. Although colonoscopy is currently considered the most&#xD;
      effective method for detecting advanced adenomas, individuals may be reluctant to undergo&#xD;
      colonoscopy due to the uncomfortable feeling and the relatively high cost. Conversely, stool&#xD;
      tests are relatively cheap and more readily accepted. Fecal immunochemical test (FIT) is&#xD;
      economic and easy to use in colorectal cancer screening. However, the common used qFIT is&#xD;
      insufficiently sensitive to the minor hemorrhage of advanced adenomas, and the sensitivity is&#xD;
      about only 27% to 47%. To improve the detection rate of colorectal advanced adenoma,&#xD;
      Ultra-sensitivity quantitative fecal immunochemical test (us-qFIT) improves technology and&#xD;
      can detect fecal hemoglobin in extremely low concentration quantificationally. The&#xD;
      investigators design this research to prove the diagnostic accuracy of us-qFIT in detecting&#xD;
      colorectal advanced adenoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 19, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The accuracy of us-qFIT to diagnose colorectal advanced adenoma.</measure>
    <time_frame>24 months</time_frame>
    <description>The sensitivity, specificity, positive predictive value and negative predictive value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The accuracy of us-qFIT to diagnose colorectal cancer.</measure>
    <time_frame>24 months</time_frame>
    <description>The sensitivity, specificity, positive predictive value and negative predictive value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The accuracy of us-qFIT to diagnose high-risk adenoma.</measure>
    <time_frame>24 months</time_frame>
    <description>The sensitivity, specificity, positive predictive value and negative predictive value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Develop a predictive model of advanced colorectal neoplasms which includes the value of us-qFIT.</measure>
    <time_frame>24 months</time_frame>
    <description>Develop a predictive model of CRC or advanced colorectal neoplasm which includes qFIT, age ,sex, CRC family history, diet and so on.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Colorectal Neoplasm</condition>
  <arm_group>
    <arm_group_label>Us-qFIT group</arm_group_label>
    <description>People in this group will detect fecal hemoglobin concentration by us-qFIT before colonoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>The us-qFIT and colonoscopy with pathological examination</intervention_name>
    <description>Detect fecal hemoglobin concentration by us-qFIT before colonoscopy, detect colon lesions using colonoscopy and pathological examination.</description>
    <arm_group_label>Us-qFIT group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Continuous participants intending to undergo colonoscopy and meet the inclusion and&#xD;
        exclusion criteria from the 5 hospitals were enrolled.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  50-75 years old people;&#xD;
&#xD;
          -  People sign an &quot;informed consent form&quot;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  People with history of colorectal surgery;&#xD;
&#xD;
          -  People with history of colorectal cancer;&#xD;
&#xD;
          -  People with history of other diseases that may produce fecal blood, such as&#xD;
             inflammatory bowel disease, ischemic enteritis, vascular alformation of intestine,&#xD;
             intestinal tuberculosis or Non-Hodgkin's lymphoma involving digestive tract;&#xD;
&#xD;
          -  People with symptoms including visible rectal bleeding, hematuria, hemorrhoid bleeds,&#xD;
             severe and acute diarrhea and watery stool;&#xD;
&#xD;
          -  People are in pregnancy, lactation or menstrual phase;&#xD;
&#xD;
          -  People with severe congestive heart failure or other sever disease cause cannot&#xD;
             tolerate colonoscopy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanqing Li, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Qilu Hospital, Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruchen Zhou, MD</last_name>
    <phone>15949702165</phone>
    <email>sdlwzrc@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yueyue Li, PhD</last_name>
    <phone>18560089751</phone>
    <email>lyynqj@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Binzhou Medical University Hospotal</name>
      <address>
        <city>Binzhou</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chengxia Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Lixia District of Jinan</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongjun LiZhang</last_name>
      <phone>+8613515415912</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanqing Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weihai Municipal Hospital</name>
      <address>
        <city>Weihai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaozhong Gao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Tongji Hospital, Tongji University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuzhang Xu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bangmao Wang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 19, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <keyword>Colorectal Neoplasm</keyword>
  <keyword>Occult Bleeding</keyword>
  <keyword>Quantitative fecal immunochemical test</keyword>
  <keyword>Colorectal Cancer</keyword>
  <keyword>Adenoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

